UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000022969
Receipt No. R000026479
Official scientific title of the study Deep brain stimulation(DBS) for intractable obsessive-compulsive disorders(OCDs). randomized crossover trial and open-label trial
Date of disclosure of the study information 2016/07/07
Last modified on 2016/07/01 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Deep brain stimulation(DBS) for intractable obsessive-compulsive disorders(OCDs).
randomized crossover trial and open-label trial
Title of the study (Brief title) Deep brain stimulation for intractable obsessive-compulsive disorders (DBS for OCDs)
Region
Japan

Condition
Condition Intractable obsessive-compulsive disorders
Classification by specialty
Psychiatry Neurosurgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Observe the efficacy of DBS of the bilateral anterior internal capsule/ ventral striatum (AIC/VS-DBS) for intractable OCDs
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes more than 35% improvement of Yale Brown Obsessive Compulsive Scale (Y-BOCS) at 12 months after the initiation of AIC/VS-DBS.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -but assessor(s) are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as adjustment factor in dynamic allocation.
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Deep brain stimulation group
Interventions/Control_2 Sham deep brain stimulation group
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >=
Gender Male and Female
Key inclusion criteria 20 to 70 year-old OCD patients diagnosed by DSM-5 with the informed consent.
Y-BOCS score of 30/40 or more and Global Assessment of Functioning scores of 45 or less.
Refractory against medication and cognitive behavioral therapy for more than 5 years.
Key exclusion criteria Other psychiatric illness (autism, schizophrenia, bipolar disorders, depression, drug addiction), and brain disease (epilepsy, trauma, cerebro-vascular disease, neuro-degenerative disease) except tic and Tourette syndrome.
Severe cardiac diseases, pulmonary diseases blood diseases
Pregnant or during breast-feeding.
Whom researchers judged as inappropriate
Target sample size 20

Research contact person
Name of lead principal investigator Kenji Sugiyama
Organization Hamamatsu University School of Medicine
Division name Department of Neurosurgery
Address 1-20-1, Handa-yama, Higashi-ku, Hamamatsu
TEL 053-435-2283
Email kesugi@hama-med.ac.jp

Public contact
Name of contact person Kenji Sugiyama
Organization Hamamatsu University School of Medicine
Division name Department of Neurosurgery
Address 1-20-1, Handa-yama, Higashi-ku, Hamamatsu
TEL 053-435-2283
Homepage URL
Email kesugi@hama-med.ac.jp

Sponsor
Institute Hamamatsu University School of Medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Hamamatsu University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 07 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2015 Year 11 Month 16 Day
Anticipated trial start date
2016 Year 07 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 01 Day
Last modified on
2016 Year 07 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026479